drugset / Trial / NCT03038828
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Phase 1
Terminated
8 enrolled
CEL-SCI Corporation
Ergomed Clinical Research Inc. · collabUnited States Naval Medical Center, San Diego · collab
Non-randomizedFactorialOpen-labelOther
Summary
Study is a dose escalation study. Fifteen patients will be enrolled in 2 treatment cohorts. Five participants (cohort A) will be treated with 200IU Multikine daily, 5 days/week for 2 weeks, off 2 weeks, then again 5 days/week for 2 weeks. If no serious adverse events are noted in cohort A patients, ten participants will be treated in cohort B. Cohort B participants will be treated the same as cohort A participants except that dose will be increased to 400IU Multikine per day.
Timeline
- Start
- 2015-04
- Primary completion
- 2018-06
- Completion
- 2018-09
Outcome
Outcome not reported
Stopped (Enrollment): “Insufficient enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leukocyte Interleukin | Unknown | 200 iu | — |
| Subject | Leukocyte Interleukin | Unknown | 400 iu | — |